| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Feb 14, 2025 | ZEVRA THERAPEUTICS, INC. | SVP, Finance & Corp Controller | Sell | 23.8 | -3,000 | -15.51% | ✓ | $23.6K |
| Mar 10, 2023 | Mar 13, 2023 | ZEVRA THERAPEUTICS, INC. | SVP, Corporate Controller | Buy | 90.0 | +1,200 | 36.93% | ✗ | $5K |
| Mar 13, 2020 | Mar 16, 2020 | ZEVRA THERAPEUTICS, INC. | VP, Corporate Controller | Buy | 90.0 | +4,000 | 28.57% | ✗ | $800 |
| Mar 9, 2020 | Mar 10, 2020 | ZEVRA THERAPEUTICS, INC. | VP, Corporate Controller | Buy | 90.0 | +8,000 | 133.33% | ✗ | $2K |
| Sep 24, 2019 | Sep 25, 2019 | ZEVRA THERAPEUTICS, INC. | VP, Corporate Controller | Buy | 90.0 | +3,000 | 100.00% | ✗ | $2.2K |
| Oct 11, 2018 | Oct 15, 2018 | ZEVRA THERAPEUTICS, INC. | VP, Corporate Controller | Buy | 90.0 | +3,000 | 100.00% | ✗ | $7.6K |